Filing Details
- Accession Number:
- 0001209191-20-039080
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-06-26 16:23:23
- Reporting Period:
- 2020-06-24
- Accepted Time:
- 2020-06-26 16:23:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1679082 | Myovant Sciences Ltd. | MYOV | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1714080 | Camilo Juan Ferreira Arjona | C/O Myovant Sciences Inc. 2000 Sierra Point Parkway, 9Th Floor Brisbane CA 94005 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-06-24 | 10,946 | $7.78 | 156,061 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-06-24 | 6,500 | $7.78 | 162,561 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-06-24 | 17,446 | $20.00 | 145,115 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-06-24 | 10,946 | $0.00 | 10,946 | $7.78 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-06-24 | 6,500 | $0.00 | 6,500 | $7.78 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 245,000 | 2027-08-14 | No | 4 | M | Direct | |
| 80,550 | 2028-04-15 | No | 4 | M | Direct |
Footnotes
- Shares sold pursuant to a 10b5-1 trading plan.
- 1/4 of the common shares underlying this option vested on August 15, 2018, and 1/16 of the common shares underlying this option vest each quarter thereafter, provided the Reporting Person has provided continuous service to the Issuer or its affiliates on each such date. Of the vested portion of this option, 130,000 shares cannot be exercised for 12 months commencing on August 26, 2019, subject to certain exceptions provided by the Reporting Person's applicable option agreement.
- 1/4 of the common shares underlying this option vested on April 16, 2019, and 1/16 of the common shares underlying this option vest each quarter thereafter, provided the Reporting Person has provided continuous service to the Issuer or its affiliates on each such date. Of the vested portion of this option, 27,204 shares cannot be exercised for 12 months commencing on August 26, 2019, subject to certain exceptions provided by the Reporting Person's applicable option agreement.
Billionaire Hedge Funds
